Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Marvel Biosciences Corp (MRVL.VN)

Marvel Biosciences Corp (MRVL.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Marvel Biosciences Announces Private Placement Update Newsfile - Fri Jun 21, 3:02PM CDT

Calgary, Alberta--(Newsfile Corp. - June 21, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), wishes to...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences Announces Private Placement Newsfile - Thu May 16, 5:50PM CDT

Calgary, Alberta--(Newsfile Corp. - May 16, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences Announces Positive Interim Results on Tau Phosphorylation with MB-204 Newsfile - Mon Mar 25, 8:08AM CDT

Calgary, Alberta--(Newsfile Corp. - March 25, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences Announces Positive Interim Results for Autism Treatment with MB-204 Newsfile - Tue Mar 12, 8:06AM CDT

Calgary, Alberta--(Newsfile Corp. - March 12, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF), and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences Announces Testing MB-204 on Autism by French University Newsfile - Tue Feb 20, 3:38PM CST

Calgary, Alberta--(Newsfile Corp. - February 20, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences Announces Closing of Non-Brokered Private Placement Newsfile - Fri Jan 19, 3:40PM CST

Calgary, Alberta--(Newsfile Corp. - January 19, 2024) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), is pleased...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences to Collaborate with Tau Expert Dr. Emmanuel Planel Newsfile - Mon Jan 8, 3:40PM CST

Calgary, Alberta--(Newsfile Corp. - January 8, 2024) -  Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Marvel Biosciences Invited to Test MB-204 on Autism by French University Newsfile - Thu Nov 16, 2023

Calgary, Alberta--(Newsfile Corp. - November 16, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)
Stocks in play: Marvel Biosciences Corp Baystreet - Tue Aug 22, 2023

Announces that it has successfully completed its 4-week good laboratory practice, FDA investigational ...

MRVL.VN : 0.120 (unch)
Marvel Announces Successful Completion of Toxicology Study in Preparation for Phase 1 Human Trials Newsfile - Tue Aug 22, 2023

Calgary, Alberta--(Newsfile Corp. - August 22, 2023) - Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"),...

MBCOF : 0.0854 (+3.52%)
MRVL.VN : 0.120 (unch)

Barchart Exclusives

3 Standout Stocks to Buy for Q3 2024 Barchart - 48 minutes ago
As we enter the third quarter of 2024, here are three promising stocks investors could consider buying. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot